Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Primary candidates for GLP-1 therapy include: Patients with type 2 diabetes and inadequate glycemic control despite metformin therapy Individuals with type 2 diabetes and established atherosclerotic cardiovascular disease Patients with type 2 diabetes and multiple cardiovascular risk factors (hypertension, dyslipidemia, obesity) Adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities Patients with metabolic syndrome who have not achieved adequate risk factor control with lifestyle modification For patients with dyslipidemia, GLP-1 agents may be particularly valuable when combined with statin therapy in those who have not reached LDL-C goals or who have persistent hypertriglyceridemia despite statin treatment
PlexusDx provides compounded GLP-1 medications from licensed 503A pharmacies with optional Precision Peptide Genetic Testing ($99-$298)
This single step prevents a world of hurt
It works through brain pathways, not hormones or blood flow
US$ 27.09
US$ 28.18
US$ 25.53
US$ 27.45
